Michael Conick Hanley Jr., Chief Commercial Officer at Aeglea BioTherapeutics, Inc. (AGLE), bought 28,200 shares at $0.71 ($20K) on 2022-06-08, disclosed to the SEC on 2022-06-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.